Further subtypes include HER 2 + (overexpression of HER2 along with ER/PR+), basal-like Triple-negative breast cancer (TNBC, defined by ER−, PR−, HER2−), among other specific subtypes (2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.